Georgeta Liga 1, I. Al. Checheriţă 1, Roxana C. Sandulovici 2, A. Niculae 1, Daniela Rădulescu 1, Al. Ciocâlteu 1
1 “Carol Davila” University of Medicine and Pharmacy, Bucharest, Emergency Saint John Hospital
2 “Carol Davila” University of Medicine and Pharmacy, Bucharest, Department of Biostatistics
Abstract
Chronic renal diseases are often accompanied by systemic hypertension, which, in turn, accelerates progression of renal dysfunction. The vast majority of actual guidelines recommend ACEI and/ or ARB as first choice of antihypertensive treatment. The study presented compares the evolution of 157 patients with chronic renal failure and renoparenchymatous hypertension treated with different antihypertensive regimens.